| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.2M | +11.7% |
| R&D Expense | $109.4M | -15.9% |
| SG&A Expense | $37.9M | -18.4% |
| Operating Income | -$148.3M | +11.0% |
| Pre-tax Income | -$148.7M | +0.3% |
| Income Tax | -$550K | -6011.1% |
| Net Income | -$148.1M | +0.7% |
| EPS (Basic) | -$1.59 | +3.6% |
| EPS (Diluted) | -$1.59 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.4M | -24.1% |
| Accounts Receivable | $69K | -74.0% |
| Current Assets | $145.2M | -33.8% |
| Total Assets | $175.4M | -44.0% |
| Current Liabilities | $25.4M | -17.1% |
| Total Liabilities | $53.2M | -11.9% |
| Stockholders' Equity | $122.2M | -51.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$111.0M | +19.7% |
| Capital Expenditures | $1.4M | -72.2% |
| Investing Cash Flow | $102.2M | +18.0% |
| Financing Cash Flow | $4.8M | -71.2% |
| Free Cash Flow | -$112.4M | +21.5% |
| +3.6% |